State Advocacy Key Issues

ACR state advocacy

The ACR works with the Affiliate Society Council, representing local and state rheumatology societies, and other advocacy coalitions to affect positive change at the state legislative and regulatory levels. On key issues important to the rheumatology community, ACR initiatives include policy tracking and analysis, providing comments on legislation or rules being considered and also arranging testimony at hearings by our members. See below for information on several of the current issues being tracked on the state level.

Biosimilar Substitution

Timely notification of changes in patient therapies is necessary to ensure patient safety is at the forefront of health care decisions. The ACR advocates its preference that notification of any substitution be provided in advance of dispensation. See more information on ACR state advocacy efforts related to biosimilars.

Biosimilar ACR Comments GA HB 195
Biosimilar ACR Letter NC HB 195

Prior Authorization

The ACR supports policies that enable the treating physician to choose the most appropriate treatment for the patient without the hindrance of excessive administrative processes for approval from insurers.

Specialty Tiers

Specialty tiering practices utilized by insurance carriers result in excessive patient financial burden and greatly reduced access to medically-necessary treatments. See more ;information about ACR state advocacy efforts to rein in specialty tier practices.

Specialty Tiers MA SB 477
RI SB 2501 ACR - House Support Letter Step Therapy Specialty Tier

Step Therapy

The ACR opposes step therapy practices, also known as fail-first policies, step protocol, sequencing or tiering. Access to treatment should be reasonable and timely without unnecessary barriers to medically necessary care. See more information on ACR state advocacy efforts related to step therapy.

ACR NY Step Therapy Comments 2015
CT SB 394 ACR Support Letter Step Therapy Requirements
RI SB 2501 ACR - House Support Letter Step Therapy Specialty Tier